Anondita Medicare Ltd
Founded in March 2024, Anondita Medicare Limited manufactures flavored male condoms, with its flagship product branded as “COBRA.”[1]
- Market Cap ₹ 1,099 Cr.
- Current Price ₹ 608
- High / Low ₹ 629 / 262
- Stock P/E 102
- Book Value ₹
- Dividend Yield 0.00 %
- ROCE 62.1 %
- ROE 76.0 %
- Face Value ₹ 10.0
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
| Operating Profit |
| OPM % |
| Interest |
| Depreciation |
| Profit before tax |
| Tax % |
| EPS in Rs |
| Raw PDF |
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2024 1m | Mar 2025 | |
|---|---|---|
| 0 | 61 | |
| 0 | 43 | |
| Operating Profit | 0 | 18 |
| OPM % | 30% | |
| 0 | 0 | |
| Interest | 0 | 3 |
| Depreciation | 0 | 1 |
| Profit before tax | 0 | 14 |
| Tax % | 25% | |
| 0 | 11 | |
| EPS in Rs | 0.00 | 8.12 |
| Dividend Payout % | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | 76% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2024 | Mar 2025 | |
|---|---|---|
| Equity Capital | 0.10 | 13 |
| Reserves | 0 | 15 |
| 0 | 27 | |
| 0 | 9 | |
| Total Liabilities | 0 | 64 |
| 0 | 13 | |
| CWIP | 0 | 6 |
| Investments | 0 | 4 |
| 0 | 41 | |
| Total Assets | 0 | 64 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2024 | Mar 2025 | |
|---|---|---|
| -0 | 6 | |
| 0 | -23 | |
| 0 | 17 | |
| Net Cash Flow | 0 | 0 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2024 | Mar 2025 | |
|---|---|---|
| Debtor Days | 100 | |
| Inventory Days | 115 | |
| Days Payable | 45 | |
| Cash Conversion Cycle | 170 | |
| Working Capital Days | 101 | |
| ROCE % | 62% |
Documents
Announcements
-
Cessation
29 October 2025 - Sonia Ghosh resigned as Whole-time Director effective 29 Oct 2025; personal reasons.
-
Appointment
22 October 2025 - Amartya Ghosh appointed Whole Time Director (Additional) for five years, effective 22 Oct 2025, subject to shareholder approval.
-
Updates
8 October 2025 - Anondita Medicare awarded L1 CMSS GeM tender (GEM/2025/B/6416312, 04-Jul-2025) to supply contraceptives; condoms 197.7M.
-
Quarterly Compliance Report on Corporate governance - within 21 days from the end of the quarter
8 October 2025 - Anondita Medicare Limited has informed regarding Submission of the Compliance Report on Corporate Governance for the Q_ FY 20__-__
-
Certificate under SEBI (Depositories and Participants) Regulations, 2018
8 October 2025 - RTA confirms dematerialisation for ISIN INE0VTV01012 for quarter ended 30/09/2025.
Annual reports
No data available.
Business Profile[1]
Anondita Medicare manufactures male (and recently, female) condoms, flagship brand “COBRA,” with in-house printing/packaging and 100% electronic testing.